NASDAQ:VICL Vical (VICL) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free VICL Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.68▼$3.1552-Week Range N/AVolume35,024 shsAverage Volume1.44 million shsMarket Capitalization$21.01 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesSocial MediaStock AnalysisHeadlinesSocial Media Get Vical alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Vical Stock (NASDAQ:VICL)Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The company was founded in 1987 and is headquartered in San Diego, California.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. VICL Stock News HeadlinesMarch 29, 2024 | msn.comEvan Gershkovich’s sister was the quiet one. Now she’s his voice.March 29, 2024 | msn.comSong Suffragettes celebrates 10 years with Wynonna, female country chart-toppers, moreApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 29, 2024 | theguardian.comSong lyrics getting simpler, more repetitive, angry and self-obsessed – studyMarch 29, 2024 | msn.comBeyoncé’s Younger Daughter Rumi Carter Joins Her on New Song ‘Protector’March 29, 2024 | msn.comBeyoncé features Shaboozey on her song 'Spaghettii': Who is the hip-hop, country artist?March 28, 2024 | msn.comCreed frontman Scott Stapp on singing his 'life story,' moving to Nashville and finding a dream teamMarch 28, 2024 | msn.comBBC stands by replacing singer with AI-generated voiceApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 28, 2024 | msn.comFunniest misheard Beyoncé lyrics, from 'Singing lettuce' to 'No bottom knee'March 28, 2024 | msn.comSong Lyrics Are Now More Repetitive and Simple, Study ConfirmsMarch 28, 2024 | msn.comSong lyrics have become angrier since the 80s, study showsMarch 28, 2024 | msn.comBachelor Joey Graziadei Reveals the Taylor Swift Song That Reminds Him of New Fiancée Kelsey AndersonMarch 28, 2024 | barrons.comSong Lyrics Are Getting Simpler, More Repetitive: StudyMarch 28, 2024 | yahoo.comVampire Weekend Share Video for New Song “Mary Boone”: WatchMarch 28, 2024 | msn.comFans freak hearing Kanye West’s wife Bianca Censori’s voice for first time in old videoMarch 28, 2024 | msn.comBeyoncé's ‘Cowboy Carter’ tracklist is a puzzle. What we've deciphered so farMarch 28, 2024 | foxnews.comThis song is our storyMarch 28, 2024 | chicago.suntimes.comWhat happens when new White Sox voice John Schriffen meets former White Sox voice Jason Benetti?March 28, 2024 | msn.comPaul McCartney Shares the Story Behind His Favorite Song He Ever Wrote—“Here, There and Everywhere”March 28, 2024 | msn.comReba McEntire Gets Gets Choked Up Over 'The Voice' Contestant’s Emotional Connection To Luke Combs SongMarch 28, 2024 | yahoo.comVocal supergroup säje, Easter egg hunts, Asante drumming: Things to do in SeacoastMarch 27, 2024 | yahoo.comSinging to the top: Hope Arrazola makes history at Abilene HighMarch 27, 2024 | msn.comJohn Legend compares Alabama ‘Voice’ singer to icon: ‘A pure, beautiful vocalist like Whitney’March 27, 2024 | msn.comMacaulay Culkin's birthday message to Brenda Song includes a funny requestMarch 27, 2024 | msn.comMacaulay Culkin May Have Snuck A 'Home Alone' Nod Into Fiancée Brenda Song's Birthday TributeMarch 27, 2024 | msn.comHow Jarred Johnson and TransitMatters give voice to the frustrated riders of the MBTASee More Headlines Receive VICL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/19/2019Today4/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological Products, Except Diagnostic Sub-IndustryBiotechnology Current SymbolNASDAQ:VICL CUSIP92560210 CIK819050 Webwww.vical.com Phone858-646-1100FaxN/AEmployees30Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,250,000.00 Net Margins-1,002.10% Pretax MarginN/A Return on Equity-29.46% Return on Assets-27.85% Debt Debt-to-Equity RatioN/A Current Ratio36.84 Quick Ratio36.84 Sales & Book Value Annual Sales$1.62 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.82 per share Price / BookN/AMiscellaneous Outstanding Shares22,840,000Free FloatN/AMarket Cap$21.01 million OptionableNot Optionable Beta0.32 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Vijay B. Samant (Age 66)CEO, Pres & Director Dr. Lawrence Russell Smith (Age 58)Sr. VP of Research Mr. Anthony Alan Ramos (Age 52)VP, CFO & Chief Accounting Officer Dr. Mammen P. Mammen Jr. (Age 55)Former Sr. VP of Clinical Devel. Key CompetitorsSAB BiotherapeuticsNASDAQ:SABSAIM ImmunoTechNYSE:AIMEvaxion Biotech A/SNASDAQ:EVAXZIVO BioscienceNASDAQ:ZIVOAptose BiosciencesNASDAQ:APTOView All Competitors VICL Stock Analysis - Frequently Asked Questions How were Vical's earnings last quarter? Vical Incorporated (NASDAQ:VICL) announced its earnings results on Tuesday, February, 19th. The biotechnology company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). The biotechnology company had revenue of $0.12 million for the quarter, compared to the consensus estimate of $0.04 million. Vical had a negative net margin of 1,002.10% and a negative trailing twelve-month return on equity of 29.46%. What other stocks do shareholders of Vical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vical investors own include Synergy Pharmaceuticals (SGYP), Cytori Therapeutics (CYTX), Inovio Pharmaceuticals (INO), Caladrius Biosciences (CLBS), Catalyst Pharmaceuticals (CPRX), Trevena (TRVN), CTI BioPharma (CTIC), Idera Pharmaceuticals (IDRA), Agenus (AGEN) and Curis (CRIS). This page (NASDAQ:VICL) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryYou Won't Believe Who Bezos is Working With to Fight Alzheimer'sBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
